CoChat

Defining the Mechanism of Action and Enzymatic Selectivity of Psammaplin A against Its Epigenetic Targets

The DOI matches its Crossref record; 80 of the 81 references it cites were found in a registry or an index.

Abstract

Psammaplin A (11c) is a marine metabolite previously reported to be a potent inhibitor of two classes of epigenetic enzymes: histone deacetylases and DNA methyltransferases. The design and synthesis of a focused library based on the psammaplin A core has been carried out to probe the molecular features of this molecule responsible for its activity. By direct in vitro assay of the free thiol generated upon reduction of the dimeric psammaplin scaffold, we have unambiguously demonstrated that 11c functions as a natural prodrug, with the reduced form being highly potent against HDAC1 in vitro (IC(50) 0.9 nM). Furthermore, we have shown it to have high isoform selectivity, being 360-fold selective for HDAC1 over HDAC6 and more than 1000-fold less potent against HDAC7 and HDAC8. SAR around our focused library revealed a number of features, most notably the oxime functionality to be important to this selectivity. Many of the compounds show significant cytotoxicity in A549, MCF7, and W138 cells, with the SAR of cytotoxicity correlating to HDAC inhibition. Furthermore, compound treatment causes upregulation of histone acetylation but little effect on tubulin acetylation. Finally, we have found no evidence for 11c functioning as a DNMT inhibitor.

Overview

Integrity signals

Registry

Crossref · 10.1021/jm2016182

Cites

80 of 80 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 80 references

Research works printed but not linked: 4

  1. Fang M. Z., 2003, Cancer Res., 63, 7563
  2. Kim D., 1999, Anticancer Res., 19, 4085
  3. Furumai R., 2002, Cancer Res., 62, 4916
  4. Zhu Y., 2009, Mol. Med. Rep., 2, 743

Cited by

Items 101–108 of 108

Metadata

Authors
Baud, M. G. J., Leiser, T., Haus, P., Samlal, S., Wong, A. C., Wood, R. J., Petrucci, V., Gunaratnam, M., Hughes, S. M., Buluwela, L., Turlais, F., Neidle, S., Meyer-Almes, F.-J., White, A. J. P., & Fuchter, M. J.
Affiliations
  • Imperial College London (GB)
  • Darmstadt University of Applied Sciences (DE)
  • Cancer Research Technology Discovery Laboratories, Wolfson Institute for Biomedical Research, The Cruciform Building, Gower Street, London WC1E 6BT, United Kingdom
  • Cancer Research UK (GB)
  • Department of Surgery and Cancer, Imperial College London, Du Cane Road, London W12 0NN, United Kingdom
  • Department of Chemical Engineering and Biotechnology, University of Applied Sciences, Schnittspahnstrasse 12, 64287 Darmstadt, Germany
Corresponding author
Fuchter, Matthew J.
Venue
Journal of Medicinal Chemistry
Published
2012-02-09
Volume
55
Issue
4
Pages
1731-1750
ISSN
  • 0022-2623 (ISSN-L)
  • 1520-4804
OpenAlex
W2064944074
Cited by
100
References
81
Citations by year
2026: 3 · 2025: 2 · 2024: 5 · 2023: 7 · 2022: 6 · 2021: 10 · 2020: 5 · 2019: 7 · 2018: 8 · 2017: 7 · 2016: 8 · 2015: 12 · 2014: 7 · 2013: 6 · 2012: 7
FWCI
4.11
Type
journal article
Language
en
Open access
closed
Locations
  • Journal of Medicinal Chemistry (publishedVersion)
  • PubMed (publishedVersion)
  • ePrints Soton (University of Southampton) (submittedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Histone Deacetylase Inhibitors Research
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Epigenetics and DNA Methylation
  • Physical Sciences › Chemistry › Organic Chemistry › Isoquinoline Alkaloid Synthesis
Keywords
psammaplin A, histone deacetylase inhibitors, HDAC1, HDAC isoform selectivity, structure-activity relationship, marine natural products, cytotoxicity, histone acetylation, DNA methyltransferase inhibition, focused libraries
MeSH terms
Acetylation, Antineoplastic Agents, Disulfides, DNA (Cytosine-5-)-Methyltransferases, Drug Screening Assays, Antitumor, Histones, Humans, Isoenzymes, Models, Molecular, Prodrugs, Structure-Activity Relationship, Tubulin, Tyrosine, Crystallography, X-Ray, Dimerization, Epigenesis, Genetic, Cell Line, Tumor, Histone Deacetylase Inhibitors

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.